Publications

2026

2025

29. Giri A, Shin Y, Ha J, Chae S, Shrestha P, Pham KY, Kwon TK, Park JH and, Jeong JH, Lee NK and Yook S (2025) Design of cathepsin-sensitive linkers for tumor-selective bioconjugate drug delivery. J Control Release. 2025 Nov 10;387:114197.

28. Huang M#, Wang D#, Huang J, Bae AN, Xia Y, Zhao X, Mortaja M, Azin M, Collier M R, Semenov Y R, Mino-Kenudson M, Park JH* and Demehri S* (2025) Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens. Nat. Commun. 2025 Jun 27;16(1):5360. *Corresponding author

27. Bae AN, Mortaja M, Yeung Y P, Park JH* and Demehri S* (2025) Tropisetron suppresses chronic pancreatitis and pancreatic cancer by blocking interleukin 33 expression. Cancers. 2025 Jun 22;17(13), 2087. *Corresponding author

26. Choi J, Kim J, Jung YW, Park JH and Lee JH (2025) Neurotrophic receptor tyrosine kinase 3 as a prognostic biomarker in breast cancer using bioinformatics analysis. Medicina. 2025 Mar 8;61(3):474.

25. Moon SW, Lee JC, Lee JH, Kim TY and Park JH* (2025) Clinical and prognostic value of VHL in Korean patients with Rectal cancer. Medicina. 2025 Feb 10;61(2):306. *Corresponding author

24. Bae AN, Lee H, Yang H, Mukherjee S, Im SS, Lee JH and Park JH* (2025) Enhancing regulatory T cell function via mevalonate pathway inhibition prevents liver fibrosis. BBRC. 2025 Jan:742:151094. *Corresponding author

2024

23. Jung SJ, Lee CH, Bae AN, Park JH, Lee JH and Kim J (2024) Clinical and prognostic significance of TSC2 and TSC1 expression in rectal cancer. Anat Biol Anthropol. 2024 Dec 37(4):303-311.

22. Lee H, Bae AN, Yang H, Lee JH and Park JH* (2024) Modulation of PRC1 promotes anticancer effects in pancreatic cancer. Cancers. 2024 Sep 27;16(19):3310. *Corresponding author

21. Zhou EY, Xia Y, Oka T, Higuchi H, Hasegawa T, Park JH, Marchese E, Oliver-Garcia VS, Azin M, Conrad DN, Smith SS, Neel VA, Demehri S (2024) Cutaneotropic polyomavirus abundance in the Non-lesional skin of keratinocyte carcinoma patients: a cross-sectional study. J Am Acad Dermatol. 2024 Jul 13:S0190-9622(24)02489-7.

20. Chae M, Lee JH, Park JH, Keum DY, Jung H, Lee Y, Lee DH (2024) Different role of TRF1 and TRF2 expression in non-small cell lung cancers. Onco Targets Ther. 2024 Jun 4:17:463-469.

19. Park JH, Mortaja M, Son H G, Zhao X, Sloat M L, Azin M, Wang J, Collier M R, Tummala K S, Mandinova A, Bardeesy N, Semenov Y R, Mino-Kenudson M and Demehri S (2024) Statin prevents cancer development in chronic inflammation by blocking IL-33 expression. Nat. Commun. 2024 May 30;15(1):4099.

18. Jeong EA, Lee MH, Bae AN, Kim J, Park JH and Lee JH (2024) A Comprehensive Analysis of HOXB13 Expression in Hepatocellular Carcinoma. Medicina. 2024 Apr 26;60(5):716

2023

17. Bae AN, Kim J, Park JH, Lee JH and Choi E (2023) Comprehensive analysis of NKX3.2 in liver hepatocellular carcinoma by bigdata. Medicina. 2023 Oct 6;59(10):1782

16. Park JH, Mortaja M, Azin M, Nazarian RM and Demehri S (2023) Nuclear IL-33 in fibroblasts promotes skin fibrosis. J Invest Dermatol. 2023 Jul;143(7):1302-1306.e4

15. Park JH (2023) Chronic disease with the immune system in internal organs. Anat Biol Anthropol. 2023 Jun;36(2):43-50.

2022

14. Cheon SY#, Park JH#, Ameri AH, Lee RT, Nazarian RM and Demehri S (2022) IL-33/regulatory T-cell axis suppresses skin fibrosis. J Invest Dermatol. 2022 Oct 1;142(10):2668-2676. #Co-first Author

13. Boieri M, Malishkevich A, Guennoun R, Marchese E, Kroon S, Trerice KE, Awad M, Park JH, Lyer S, Kreuzer J, Haas W, Rivera MN and Demehri S (2022) CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation. J Exp Med. 2022 Jul 4;219(7):e20201963.

12. Yoo HM, Park JH, Kim JY and Chung CH (2022) Modification of ERα by UFM1 increases its stability and transactivity for breast cancer development. Mol. Cells. 2022 Jun 30;45(6):42-434.

11.  Kim J, Kang J, Yoo K, Jeong J, Park I, Park JH, Rhee J, Jeon S, Jo Y, Hann S, Seo M, Moon S, Um S, Seong RH and Kong Y (2022) Bap1/SMN axis in Dpp4+skeletal muscle mesenchymal cells regulates the neuromuscular system. JCI insight. 2022 May 23;7(10):e158380.

2021

10.  Park JH, Ameri AH, Dempsey KE, Conrad DN, Kem M, Mino-Kenudson M and Demehri S (2021) Nuclear IL-33/SMAD signaling axis promotes cancer development in chronic inflammation. EMBO J. 2021 Apr 1:40(7):e106151.

9.     Choi DW, Roh YJ, Kim S, Lee HM, Kim M, Shin D, Park JH, Cho Y, Park HH, Ok YS, Kang D, Kim JH, Tarrago L, Danial NN, Gladyshev VN, Min PK and Lee BC (2021) Development of a novel fluorescent biosensor for dynamic monitoring of metabolic methionine redox status in cells and tissues. Biosens Bioelectron. 2021 Apr 15;178:113031.

Previous (~2020)

8. Ameri AH, Moradi Tuchayi S, Zaalberg A, Park JH, Ngo KH, Li T, Lopez E, Colonna M, Lee RT, Mino-Kenudson M and Demehri S (2019) IL-33/regulator T cell axis triggers the development of a tumor-promoting immune environment in chronic inflammation. Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2646-2651.

7. Yoo KY, Jung SY, Hwang SH, Lee SM, Park JH, Nam HJ (2018) Global hemostatic assay of different target procoagulant activities of factor VIII and factor IX. Blood Res. 2018 Mar;53(1):41-48.

6. Jeon YJ, Park JH and Chung CH (2017) Interferon-stimulated gene 15 in the control of cellular response against Genotoxic stress. Mol. Cells. 2017 Feb;40(2):83-89.

5. Park JH*, Yang SW*, Park JM, Ka SH, JH Kim, YY Kong, Jeon YJ, Seol JH and Chung CH (2016) Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification. Nat. Commun. 2016 Aug 22;7:12513.

4.     Yoo HM, Park JH, Jeon YJ and Chung CH (2015) Ubiquitin-fold modifier 1 acts as a positive regulator of breast cancer. Front Endocrinol. 2015 Mar 20;6:36.

3.     Seoung MW, Ka SH, Park JH, Park JH, Yoo HM, Yang SW, Seol JH and Chung CH (2015) Deleterious c-Cbl Exon Skipping Contributes to Human Glioma. Neoplasia. 2015 Jun;17(6):518-524

2.     Park JH*, Lee SW*, Yang SW, Yoo HM, Park JM, Seong MW, Ka SH, Oh KH, Jeon YJ and Chung CH (2014) Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage. Nat. Commun. 2014 Nov 18;5:5483.

1. Lee SW, Lee MH, Park JH, Kang SH, Yoo HM, Ka SH, Oh YM, Jeon YJ and Chung CH (2012) SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage. EMBO J. 2012 Nov 28;31(23):4441-4452.